Role of microRNAs in non-alcoholic steatohepatitis

Current Pharmaceutical Design

Volumn 16, Issue 17, 2010, Pages 1952-1957

  Cheung, Onpan ^a   Sanyal, Arun J ^a  

^a MCV Box 980341   (United States)

Author keywords

Insulin resistance; Metabolic syndrome; MicroRNA; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

BILIVERDIN; CYCLIN DEPENDENT KINASE; CYTOCHROME C OXIDASE; CYTOKINE; HEPATOCYTE NUCLEAR FACTOR; HOMEODOMAIN PROTEIN; HOX PROTEIN; INITIATION FACTOR; INTERFERON REGULATORY FACTOR; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; OXYSTEROL; PHOSPHATIDYLINOSITOL KINASE; RAS PROTEIN; RECOMBINANT SOMATOMEDIN C; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR; UBIQUITIN CONJUGATING ENZYME; X BOX BINDING PROTEIN 1;

ABDOMINAL OBESITY; ARTICLE; BIOGENESIS; CARBOHYDRATE METABOLISM; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELLULAR STRESS RESPONSE; CHOLESTEROL METABOLISM; CLINICAL FEATURE; DISEASE COURSE; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HYPERINSULINEMIA; LIPID METABOLISM; LIVER CIRRHOSIS; MOLECULAR RECOGNITION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TISSUE INJURY; ANIMAL; FATTY LIVER; GENETICS; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICRORNAS; RNA, MESSENGER;

EID: 77953526530     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210791208866     Document Type: Article

References (44)

1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21 (1): 3-16.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40 (6): 1387-1395.
3. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30 (6): 1356-1362.
4. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42(2): 473-480.
5. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004; 109(6): 706-713.
6. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001; 50(10): 2384-2389.
7. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005; 11(12): 1848-1853.
8. Curat CA, Wegner V, Sengenes C, Miranville A, Tonus C, Busse R, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006; 49(4): 744-747.
9. Zhang YL, Hernandez-Ono A, Siri P, Weisberg S, Conlon D, Graham MJ, et al. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis. J Biol Chem 2006; 281(49): 37603-37615.
10. Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem 2007; 282(1): 743-751.
11. Misra A, Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 2003; 82(2): 129-146.
12. Green A, Rumberger JM, Stuart CA, Ruhoff MS. Stimulation of lipolysis by tumor necrosis factor-alpha in 3T3-L1 adipocytes is glucose dependent: implications for long-term regulation of lipolysis. Diabetes 2004; 53(1): 74-81.
13. Bruce CR, Dyck DJ. Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol 2004; 287(4): E616-621.
14. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Batkai S, et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005; 115(5): 1298-1305.
15. Puri PMF, Natarajan R, Maher JW, Kellum JM, Sanyal AJ. Differential Activation and Dysregulation of Unfolded Protein Response (UPR) in Nonalcoholic Fatty Liver Disease (NAFLD). Hepatology 2006; 44(S1): 213A.
16. Puri P, Mirshahi F, Cheung O, Natarajan R, Maher JW, Kellum JM, et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008; 134(2): 568-576.
17. Wu X, Zhang L, Gurley E, Studer E, Shang J, Wang T, et al. Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways. Hepatology 2008; 47(6): 1905-1915.
18. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabol 2006; 3(2): 87-98.
19. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438(7068): 685-689.
20. Cheung O, Puri P, Eicken C, Contos MJ, Mirshahi F, Maher JW, et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008; 48(6): 1810-1820.
21. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12(9): 735-739.
22. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific MicroRNAs. Develop Cell 2003; 5(2): 351-358.
23. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T. The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 2007; 282(11): 8256-8264.
24. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. Nuclear export of microRNA precursors. Science 2004; 303(5654): 95-98.
25. Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432(7014): 231-235.
26. Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Develop 2001; 15(20): 2654-2659.
27. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404(6775): 293-296.
28. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75(5): 843-854.
29. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-297.
30. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 2005; 309(5740): 1573-1576.
31. Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, Chaudhuri A, et al. MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 2004; 36(10): 1079-1083.
32. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304(5670): 594-556.
33. Guo HS, Xie Q, Fei JF, Chua NH. MicroRNA directs mRNA cleavage of the transcription factor NAC1 to downregulate auxin signals for arabidopsis lateral root development. Plant Cell 2005; 17(5): 1376-1386.
34. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005; 122(4): 553-563.
35. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, et al. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 2005; 120(5): 623-634.
36. Nottrott S, Simard MJ, Richter JD. Human let-7a miRNA blocks protein production on actively translating polyribosomes. Nat Struct Mol Biol 2006; 13(12): 1108-1114.
37. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies.Nat Cell Biol 2005; 7(7): 719-723.
38. Lall S, Grun D, Krek A, Chen K, Wang YL, Dewey CN, et al. A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 2006; 16(5): 460-471.
39. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005; 3(3): e85.
40. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004; 1(2): 106-113.
41. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279(50): 52361-52365.
42. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Develop 2009; 23(11): 1313-1326.
43. Nakanishi N, Nakagawa Y, Tokushige N, Aoki N, Matsuzaka T, Ishii K, et al. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochem Biophys Res Commun 2009; 385(4): 492-496.
44. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432(7014): 226-230.